• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND TELIGEN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND TELIGEN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number E110
Device Problems Communication or Transmission Problem (2896); Device Operates Differently Than Expected (2913)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 04/11/2018
Event Type  malfunction  
Manufacturer Narrative
The device is being evaluated in our post market quality assurance laboratory.This product issue will be updated when evaluation is complete.
 
Event Description
Boston scientific received information that this device was explanted due to the patient receiving a heart transplant.The device was programmed to electrocautery protection mode prior to surgery.A magnet was applied due to some issues during the procedure.A health care provider reported that device interrogation following the surgery revealed the device was no longer programmed to electrocautery protection mode.The caller inquired if magnet application could have caused the programming change.A boston scientific technical services consultant stated this would not occur as a result of magnet application and the programming must have been cancelled.A boston scientific sales representative was called to the facility and was informed that device interrogation was now unsuccessful despite the use of two programmers and three wands.Additionally, the device was hot to the touch.The representative confirmed interrogation was unsuccessful and stated the device was warm.The representative also noted that the device did not respond to magnet application.The device has been returned for testing.No adverse patient effects were reported.
 
Manufacturer Narrative
This device was thoroughly inspected and analyzed upon receipt at our quality assurance laboratory.It was confirmed the device could not be telemetered.A visual examination identified a small arc mark on the exterior of the device case (image).This mark is indicative of external energy directly applied to the device case.The device case was removed to facilitate inspection and testing of the internal components.A small witness mark on the inside of the device case corresponding to the arc mark on the exterior of the case was identified.The battery voltage was measured at 0 volts.The battery was removed and replaced with an external power source.Testing revealed a high current draw.Photon emission microscopy was performed which identified a damaged area of the mixed mode integrated circuit (mmic) as the source of the high current draw.Analysis concluded this device was damaged due to exposure to external energy strong enough to damage the exterior of the device case as well as the internal circuitry of the device.This likely induced a reset which is why the device was no longer operating in electrocautery protection mode.The damage to the mmic resulted in a high current draw that rapidly depleted the battery causing the observed warming of the device and inability to interrogate it.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TELIGEN
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7615304
MDR Text Key111673127
Report Number2124215-2018-08852
Device Sequence Number1
Product Code LWP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/29/2012
Device Model NumberE110
Other Device ID NumberTELIGEN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/13/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received05/31/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age36 YR
-
-